Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, Ostano P, Alama A, Longo L, De Luca G, Dono M, Dal Bello MG, Ponassi M, Rosano C, Romano P, Cavalieri Z, Grassi M, Tagliamento M, Zullo L, Venturi C, Dellepiane C, Mastracci L, Bennicelli E, Pronzato P, Genova C, Coco S. Marconi S, et al. Among authors: mastracci l. Cancers (Basel). 2022 Jul 14;14(14):3412. doi: 10.3390/cancers14143412. Cancers (Basel). 2022. PMID: 35884472 Free PMC article.
The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma.
Fiocca R, Mastracci L, Lugaresi M, Grillo F, D'Errico A, Malvi D, Spaggiari P, Tomezzoli A, Albarello L, Ristimäki A, Bottiglieri L, Bonora E, Krishnadath KK, Raulli GD, Rosati R, Fumagalli Romario U, De Manzoni G, Räsänen J, Mattioli S. Fiocca R, et al. Among authors: mastracci l. Cancers (Basel). 2021 Oct 18;13(20):5211. doi: 10.3390/cancers13205211. Cancers (Basel). 2021. PMID: 34680360 Free PMC article.
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications.
Simbolo M, Centonze G, Giudice L, Grillo F, Maisonneuve P, Gkountakos A, Ciaparrone C, Cattaneo L, Sabella G, Giugno R, Bossi P, Spaggiari P, Del Gobbo A, Ferrero S, Mastracci L, Fabbri A, Filugelli M, Garzone G, Prinzi N, Pusceddu S, Testi A, Monti V, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: mastracci l. Cancers (Basel). 2022 Sep 24;14(19):4653. doi: 10.3390/cancers14194653. Cancers (Basel). 2022. PMID: 36230576 Free PMC article.
Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease.
Zanelli M, Parente P, Sanguedolce F, Zizzo M, Palicelli A, Bisagni A, Carosi I, Trombetta D, Mastracci L, Ricci L, Pancetti S, Martino G, Broggi G, Caltabiano R, Cavazza A, Ascani S. Zanelli M, et al. Among authors: mastracci l. Cancers (Basel). 2022 Nov 6;14(21):5458. doi: 10.3390/cancers14215458. Cancers (Basel). 2022. PMID: 36358876 Free PMC article. Review.
miRNA-221 and miRNA-483-3p Dysregulation in Esophageal Adenocarcinoma.
Bozzarelli I, Orsini A, Isidori F, Mastracci L, Malvi D, Lugaresi M, Fittipaldi S, Gozzellino L, Astolfi A, Räsänen J, D'Errico A, Rosati R, Fiocca R, Seri M, Krishnadath KK, Bonora E, Mattioli S. Bozzarelli I, et al. Among authors: mastracci l. Cancers (Basel). 2024 Jan 30;16(3):591. doi: 10.3390/cancers16030591. Cancers (Basel). 2024. PMID: 38339342 Free PMC article.
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I, Pastorino L, Andreotti V, Comandini D, Fornarini G, Grassi M, Puccini A, Tanda ET, Pastorino A, Martelli V, Mastracci L, Grillo F, Cabiddu F, Guadagno A, Coco S, Allavena E, Barbero F, Bruno W, Dalmasso B, Bellomo SE, Marchiò C, Spagnolo F, Sciallero S, Berrino E, Ghiorzo P. Vanni I, et al. Among authors: mastracci l. J Transl Med. 2024 May 15;22(1):462. doi: 10.1186/s12967-024-05227-2. J Transl Med. 2024. PMID: 38750555 Free PMC article.
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma.
Orsini A, Mastracci L, Bozzarelli I, Ferrari A, Isidori F, Fiocca R, Lugaresi M, D'Errico A, Malvi D, Cataldi-Stagetti E, Spaggiari P, Tomezzoli A, Albarello L, Ristimäki A, Bottiglieri L, Krishnadath KK, Rosati R, Fumagalli Romario U, De Manzoni G, Räsänen J, Martinelli G, Mattioli S, Bonora E, On Behalf Of The Eacsge Consortium. Orsini A, et al. Among authors: mastracci l. Cancers (Basel). 2023 Feb 23;15(5):1408. doi: 10.3390/cancers15051408. Cancers (Basel). 2023. PMID: 36900206 Free PMC article.
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: mastracci l. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.
210 results